340B: The Unintentional Profit Stream that Was Supposed to Help Patients

Teaser image for PhRMA's fact sheet titled "340B: The unintentional Profit Stream that Was Supposed to Help Patients"

The 340B Drug Pricing Program was designed to help vulnerable patients improve access to their medicines through manufacturer discounts to specific safety-net, non-profit hospitals and federally funded clinics. Unfortunately, the program has strayed far from its purpose, with more and more for-profit health care entities using these discounts for themselves.

Teaser image for PhRMA's fact sheet titled "340B: The unintentional Profit Stream that Was Supposed to Help Patients"